Advances in developing novel therapeutic strategies for Alzheimer’s disease

Alzheimer’s Disease (AD), the most prevalent neurodegenerative disease of aging, affects one in eight older Americans. Nearly all drug treatments tested for AD today have failed to show any efficacy. There is a great need for therapies to prevent and/or slow the progression of AD. The major challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jiqing, Hou, Jianwei, Ping, Jing, Cai, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291983/
https://www.ncbi.nlm.nih.gov/pubmed/30541602
http://dx.doi.org/10.1186/s13024-018-0299-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291983/
https://www.ncbi.nlm.nih.gov/pubmed/30541602
http://dx.doi.org/10.1186/s13024-018-0299-8

Ejemplares similares